Previous Article | Next Article 
Journal of Virology, January 2001, p. 867-877, Vol. 75, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.867-877.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of a Novel Element Involved in
Regulation of the Lytic Switch BZLF1 Gene Promoter of
Epstein-Barr Virus
Richard J.
Kraus,
Sarah J.
Mirocha,
Heather M.
Stephany,
Joel R.
Puchalski, and
Janet E.
Mertz*
McArdle Laboratory for Cancer Research,
University of Wisconsin Medical School, Madison, Wisconsin
53706-1599
Received 19 July 2000/Accepted 21 October 2000
Epstein-Barr virus (EBV) is a human herpesvirus capable of
establishing a latent state in B lymphocytes. EBV's BZLF1 gene product
plays a central role in regulating the switch from latency to
productive infection. Here, we identify a sequence element, 5'-CAGGTA-3', called ZV, located at nucleotides
17 to
12
relative to the transcription initiation site of the BZLF1 promoter. ZV sequence-specifically binds a cellular nuclear factor(s), ZVR. ZVR
DNA-binding activity was present in the EBV-negative B-lymphocytic cell
line DG75, the EBV-positive B-lymphocytic cell lines GG68 and 721, the
cervical cell line C33A, and the kidney cell line CV-1 but not in the
breast carcinoma cell line MCF-7. Mutations in ZV that relieve binding
of ZVR lead to a two- to fourfold increase in basal expression of the
BZLF1 promoter in DG75, C33A, and CV-1 cells. The same mutants
exhibited a 40- to 180-fold increase in tetradecanoyl phorbol
acetate-ionomycin-induced expression in DG75 cells and a 22-fold
increase in C33A cells. Thus, ZVR functions as a regulator of the BZLF1
promoter, repressing transcription when bound to the ZV site in the
absence of inducers. No differences in basal or induced transcription
between wild-type and ZV mutant BZLF1 promoters were observed in
ZVR-negative MCF-7 cells. ZVR failed to bind any of the previously
identified negative regulatory elements within the BZLF1 promoter. We
conclude that ZV functions as an important regulatory element of the
BZLF1 promoter, with ZVR likely playing important roles in the
maintenance of latency and reactivation of EBV.
*
Corresponding author. Mailing address: McArdle
Laboratory for Cancer Research, University of Wisconsin Medical School,
1400 University Ave., Madison, WI 53706-1599. Phone: (608) 262-2383. Fax: (608) 262-2824. E-mail: mertz{at}oncology.wisc.edu.
Journal of Virology, January 2001, p. 867-877, Vol. 75, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.867-877.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Feng, W.-h., Kraus, R. J., Dickerson, S. J., Lim, H. J., Jones, R. J., Yu, X., Mertz, J. E., Kenney, S. C.
(2007). ZEB1 and c-Jun Levels Contribute to the Establishment of Highly Lytic Epstein-Barr Virus Infection in Gastric AGS Cells. J. Virol.
81: 10113-10122
[Abstract]
[Full Text]
-
Huang, J., Liao, G., Chen, H., Wu, F. Y., Hutt-Fletcher, L., Hayward, G. S., Hayward, S. D.
(2006). Contribution of C/EBP Proteins to Epstein-Barr Virus Lytic Gene Expression and Replication in Epithelial Cells. J. Virol.
80: 1098-1109
[Abstract]
[Full Text]
-
Amon, W., Binne, U. K., Bryant, H., Jenkins, P. J., Karstegl, C. E., Farrell, P. J.
(2004). Lytic Cycle Gene Regulation of Epstein-Barr Virus. J. Virol.
78: 13460-13469
[Abstract]
[Full Text]
-
McNees, A. L., Mahr, J. A., Ornelles, D., Gooding, L. R.
(2004). Postinternalization Inhibition of Adenovirus Gene Expression and Infectious Virus Production in Human T-Cell Lines. J. Virol.
78: 6955-6966
[Abstract]
[Full Text]
-
Wu, F. Y., Wang, S. E., Chen, H., Wang, L., Hayward, S. D., Hayward, G. S.
(2004). CCAAT/Enhancer Binding Protein {alpha} Binds to the Epstein-Barr Virus (EBV) ZTA Protein through Oligomeric Interactions and Contributes to Cooperative Transcriptional Activation of the ZTA Promoter through Direct Binding to the ZII and ZIIIB Motifs during Induction of the EBV Lytic Cycle. J. Virol.
78: 4847-4865
[Abstract]
[Full Text]
-
Thomas, C., Dankesreiter, A., Wolf, H., Schwarzmann, F.
(2003). The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency. J. Gen. Virol.
84: 959-964
[Abstract]
[Full Text]
-
Kraus, R. J., Perrigoue, J. G., Mertz, J. E.
(2002). ZEB Negatively Regulates the Lytic-Switch BZLF1 Gene Promoter of Epstein-Barr Virus. J. Virol.
77: 199-207
[Abstract]
[Full Text]
-
Miller, I. G. Jr., El-Guindy, A.
(2002). Regulation of Epstein-Barr Virus Lytic Cycle Activation in Malignant and Nonmalignant Disease. JNCI J Natl Cancer Inst
94: 1733-1735
[Full Text]
-
Binne, U. K., Amon, W., Farrell, P. J.
(2002). Promoter Sequences Required for Reactivation of Epstein-Barr Virus from Latency. J. Virol.
76: 10282-10289
[Abstract]
[Full Text]
-
Bryant, H., Farrell, P. J.
(2002). Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency. J. Virol.
76: 10290-10298
[Abstract]
[Full Text]
-
Kraus, R. J., Ariazi, E. A., Farrell, M. L., Mertz, J. E.
(2002). Estrogen-related Receptor alpha 1 Actively Antagonizes Estrogen Receptor-regulated Transcription in MCF-7 Mammary Cells. J. Biol. Chem.
277: 24826-24834
[Abstract]
[Full Text]
-
Niller, H. H., Salamon, D., Uhlig, J., Ranf, S., Granz, M., Schwarzmann, F., Wolf, H., Minarovits, J.
(2002). Nucleoprotein Structure of Immediate-Early Promoters Zp and Rp and of oriLyt of Latent Epstein-Barr Virus Genomes. J. Virol.
76: 4113-4118
[Abstract]
[Full Text]